Rennova Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rennova Health generated cash of -$218,348, which is more than the previous year. Cash used in financing activities reached the amount of $898,485 last year. Net change in cash is therefore -$225,053.
Cash Flow
| 2012 | -3.10M | 3.32M | 0 |
|---|---|---|---|
| 2013 | -3.83M | 57K | 0 |
| 2015 | -12.56M | 4.28M | 14.70M |
| 2016 | -19.86M | 63.27K | 11.04M |
| 2017 | -17.71M | -492.53K | 18.13M |
| 2018 | -7.67M | 662.57K | 7.02M |
| 2019 | -13.56M | -658.66K | 14.23M |
| 2020 | -16.79M | -288.89K | 17.08M |
| 2021 | -8.91M | -374.47K | 9.61M |
| 2022 | -218.34K | -905.19K | 898.48K |
RNVA Cash Flow Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 724.52K | 25.35K | 16.93K | 6.87K | -1 | 70.17K | 8.83M | 2.40M | 7.82M | 7.57M |
Operating activities | ||||||||||
Net income | -3.27M | -5.27M | -17.64M | -47.25M | -13.58M | -50.92M | -32.61M | -34.73M | -3.92M | -1.42M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 469.37K | 643.55K | 700.99K | 795.20K | 1.26M | 1.71M | 3.04M | 2.74M | 176K | 9K |
Stock-based compensation expense | 0 | 0 | 0 | -51.89K | 0 | 303.04K | 1.10M | 722.82K | 695K | 175K |
| Deferred income tax benefit | 0 | 0 | 0 | -51.89K | 0 | 303.04K | 1.10M | 722.82K | 695K | 175K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -343.44K | -544.61K | 1.44M | -959.85K | -2.84M | -1.45M | 3.05M | 9.13M | -250K | 0 |
Inventories | 37.86K | 164.90K | 168.92K | 156.48K | 234.19K | -236.91K | 1.90M | -388.11K | -150K | 0 |
Accounts payable | -57.98K | 86.41K | 1.53M | 5.87M | 4.07M | 1.67M | -905.63K | 1.04M | -483K | -261K |
Cash generated by operating activities | -218.34K | -8.91M | -16.79M | -13.56M | -7.67M | -17.71M | -19.86M | -12.56M | -3.83M | -3.10M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -35.23K | 0 | -288.89K | -127 | -213.10K | -1.42M | -36.72K | -456.30K | -119K | -4K |
Acquisitions Net | 0 | 0 | 82K | -658.53K | -634.72K | 0 | 100K | 4.73M | 476K | 0 |
Cash generated by investing activities | -905.19K | -374.47K | -288.89K | -658.66K | 662.57K | -492.53K | 63.27K | 4.28M | 57K | 3.32M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 9M | 0 | 0 | 0 | 639.61K | 19.34M | 8.84M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -441.31K | 0 | 0 |
Repurchases of common stock | -9 | -244 | -684 | -100 | -47 | -6.67K | -8.34M | 0 | 0 | 0 |
Repayments of term debt | 86.72K | -1.61M | -7.03M | 241.33K | -5.28M | 13.52M | -15.34M | 6.30M | 0 | 0 |
Cash used in financing activities | 898.48K | 9.61M | 17.08M | 14.23M | 7.02M | 18.13M | 11.04M | 14.70M | 0 | 0 |
Net Change In Cash | -225.05K | 699.17K | 8.42K | 10.06K | 6.87K | -70.17K | -8.75M | 6.42M | -3.78M | 245K |
Cash at end of period | 499.47K | 724.52K | 25.35K | 16.93K | 6.87K | 0 | 77.97K | 8.83M | 4.03M | 7.82M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |